genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Special Report
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Cancer
Alpine’s Gold Standard Approach to Drug Development
Biomarkers
Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with…
Gene Therapy
Obsidian’s SWFT Response to COVID-19
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
Cancer
After Final Medicare LCD from Palmetto GBA, OncoCyte Pursues Private Coverage…
News
Epigenetics
Epigenetic Clock More Accurately Aligns Dog Age to Human Years
Coronavirus
Newer, More Dominant COVID-19 Variant Is More Infectious in the Lab
Coronavirus
Peptide Drug Discovery Could Lead to a Powerful Anti-Inflammatory
Alzheimers
New Method for Treating Myelin Disorders Discovered
Cancer
Novel Liver Cancer Mechanism Controls Development of Disease
Insights
All
Trends for 2020
Gene Therapy
Moving Forward after Two Deaths in a Gene Therapy Trial of…
Bioprocessing
Bioprocess 4.0 Approach Will Help Biopharma Achieve Regulators’ Goals
Bioprocessing
Digitalized Twin Model of the Workhorse
Bioprocessing
Mitigating Viral Contamination, a Challenge for Emerging Therapies
A-Lists
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Drug Discovery
Top 15 Best-Selling Drugs of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Epigenetics
Epigenetic Clock More Accurately Aligns Dog Age to Human Years
Coronavirus
Newer, More Dominant COVID-19 Variant Is More Infectious in the Lab
Coronavirus
Peptide Drug Discovery Could Lead to a Powerful Anti-Inflammatory
Gene Therapy
Moving Forward after Two Deaths in a Gene Therapy Trial of…
Magazine
All
Special Report
June 2020 Vol. 40 No. 6
The Human Genome Project in 2020 Hindsight
Commentary
3D Microscopy Keeps Getting Faster, Smarter, Leaner
Roundtable
Perspectives on Microscopy
Bioprocessing
Biomanufacturers Cope with Challenges of Going Continuous
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
eBooks
IsoPlexis’ Unique, Predictive Biology
eBooks
Engineering the Immune Response for Therapeutic Success
Upcoming Webinars
Packaging and Producer Cell Lines for Scalable Lentiviral Production
CRISPR-Cas9
GENcast: CRISPR Screens Speed Drug Discovery Efforts for Disease Intervention
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Tech Exclusives
Tech Exclusives
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Tech Exclusives
Nonviral Genetic Engineering of CAR T Cells
Tech Exclusives
Speedy Cuts: CRISPR On-Demand Method Developed
Tech Exclusives
Engineered Bacteria Demonstrate Antitumor Activity in Mice
Tech Exclusives
Axon Regeneration Seen for Optic Nerve and Spinal Cord Injuries
Tech Exclusives
COVID-19 Drug Candidates Found by Targeting the Viral Protease
Tech Exclusives
Ovarian Cancer Cells’ Dependence on Fat Opens up Potential New Treatment
Tech Exclusives
Forces Unite to Move Molecular Dx Out of the Gates
Tech Exclusives
Tea for Type 2: Green Tea Triggers Gene Editing System for...
Tech Exclusives
Genome Editing Heads to Primetime
Tech Exclusives
GE Healthcare, NIBRT Partner on Cell Therapy, Single-Use Bioprocessing
Tech Exclusives
Blood Test to Diagnose Brain Cancer in Development
Tech Exclusives
Tocagen Axing 65% of Staff after Cancer Immunotherapy Combination Fails Phase...
Tech Exclusives
One-Stop-Shop Genome Editing Product Launched by Inscripta
Tech Exclusives
Modular Bioprocessing Makes Adaptability a Snap
Tech Exclusives
A Nanomedicine Technology Sampler Pack
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Firm had previously rejected Astellas’ unsolicited bid of roughly $3.5 billion. [© Yuri Arcurs - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/May17_2010_495175_HandshakeBirdsEyeView_AstellasBuysOSI7721122207-2-324x160.jpg "Forces Unite to Move Molecular Dx Out of the Gates")
